Department of Immunotechnology
41 – 50 of 114
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Towards Development of Antibodies Targeting Myeloid and Regulatory T Cells in Bladder Tumours
- Master (Two yrs)
-
Mark
Mass spectrometry-based proteomic characterization of peripheral immune cells
- Master (Two yrs)
-
Mark
Immune cell landscapes in endometriosis and endometriosis-associated ovarian cancer
- Master (Two yrs)
-
Mark
The Frequency and Biological Impact of CD25 Expression in Mantle Cell Lymphoma
- Master (Two yrs)
-
Mark
The Effects of Chemotherapy on B Cells and T Cells in Blood and Tumor Tissue in Patients with Pancreatic Cancer – from Diagnosis to Terminal Disease
- Master (Two yrs)
-
Mark
Development and testing of autologous in vitro models for their ability to mimic the immune system’s response toward immunotherapies
- Master (Two yrs)
-
Mark
Characterization of SLC40A1 in Acute Myeloid Leukemia by CRISPRi Gene Editing
- Master (Two yrs)
-
Mark
Study of the immunological response from an OMV-based vaccine using ELISA
- Master (Two yrs)
-
Mark
The bispecific CD40xEpCAM antibody increase activation in human antigen presenting cell subsets and induce CD8+ T cell proliferation to a greater extent compared to monospecific antibodies
- Univ. Diploma
-
Mark
Comparative proteomic analysis of adult LMPPs and leukemic cells under stimulation of IFNa
- Master (Two yrs)